About the Authors

Thomas A. Zangle

Contributed equally to this work with: Thomas A. Zangle, Daina Burnes

Affiliation Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, United States of America

Daina Burnes

Contributed equally to this work with: Thomas A. Zangle, Daina Burnes

Affiliation Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, United States of America

Colleen Mathis

Affiliation Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, United States of America

Owen N. Witte

owenwitte@mednet.ucla.edu (ONW); mteitell@ucla.edu (MAT)

Affiliations Department of Molecular and Medical Pharmacology, University of California Los Angeles, Los Angeles, California, United States of America, Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, Los Angeles, California, United States of America, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California, United States of America, Howard Hughes Medical Institute, University of California Los Angeles, Los Angeles, California, United States of America

Michael A. Teitell

owenwitte@mednet.ucla.edu (ONW); mteitell@ucla.edu (MAT)

Affiliations Department of Pathology and Laboratory Medicine, University of California Los Angeles, Los Angeles, California, United States of America, Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles, Los Angeles, California, United States of America, Bioengineering Interdepartmental Program, University of California Los Angeles, Los Angeles, California, United States of America, Molecular Biology Institute, Jonsson Comprehensive Cancer Center, and California NanoSystems Institute, University of California Los Angeles, Los Angeles, California, United States of America

Competing Interests

T.A.Z., D.B, O.N.W., and M.A.T. have submitted a patent disclosure to the UCLA Office of Intellectual Property Administration (OIPA) regarding the work described in this paper. Also, a patent application on the LCI technology has been filed by UCLA OIPA with M.A.T. listed as a co-inventor. US patent application names and number #1: Michael A. Teitell, Jason C. Reed, and James K. Gimzewski; Optical Cytometry, US Serial Number 12/436,702 US provisional patent application names and number #2: Michael A. Teitell and Jason C. Reed; Rapid, Massively Parallel Single-Cell Drug Response Measurements Via Live Cell Interferometry, US Serial Number 61/514,353. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS One policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: TAZ DB ONW MAT. Performed the experiments: TAZ DB CM. Analyzed the data: TAZ DB ONW MAT. Contributed reagents/materials/analysis tools: TAZ DB CM. Wrote the paper: TAZ DB ONW MAT.